THC and THCV: What Are They and How Do They Differ? 2026 Comparison

Two carbon atoms. That's what separates THC from THCV, and the effect is opposite: the former stimulates a ravenous appetite, while the latter suppresses it. In 2024, about 62% of European medical marijuana patients used THC as the main component of therapy (EMCDDA, 2024), while THCV is just entering the third phase of research. This asymmetry of data leads to many marketing simplifications surrounding the younger cannabinoid.

We compare both molecules based on studies from Diabetes Care, Pharmacological Reviews, and Frontiers in Plant Science. You will learn how the C5 chain versus C3 shifts the CB1 receptor, why THCV is sometimes called a dietary cannabinoid, what the legal status of both compounds is in Poland in 2026, and what you can realistically buy in a Polish store.

KEY INFORMATION
• THC has a C5 chain, THCV has a shorter C3, which shifts the CB1 receptor from an agonist to an antagonist (Pharmacological Reviews, 2020).
• THC stimulates appetite, THCV suppresses it: 5 mg twice daily reduced fasting glucose by 12% (Diabetes Care, 2016).
• W Polsce limit THC w suszu to 0,3%, a medyczna marihuana wymaga recepty Rpw.
• No product in the u Bucha catalog declares THCV.
• A gram of flower costs 7.50-35.00 PLN (Store API, 2026-08-08).

What is the difference between THC and THCV at the molecular level?

THC and THCV share two carbon atoms in the side chain. THC, or delta-9-tetrahydrocannabinol, has a pentyl chain (C5), while THCV, or tetrahydrocannabivarin, has a propyl chain (C3). This minor change reverses how the molecule behaves at the CB1 receptor and translates into the entire pharmacological profile (Pharmacological Reviews, 2020).

Both compounds have the same dibenzopyran skeleton with hydroxyl groups and an aliphatic chain. They differ only in the length of this chain: five carbon atoms in THC, three in THCV. A chemist would call THCV a lower homologue. Their molecular formulas also diverge, C21H30O2 for THC versus C19H26O2 for THCV.

Why do two atoms change so much? The side chain enters the binding pocket of the CB1 receptor and determines the strength of the contact. The longer C5 stabilizes the binding and shifts the receptor to an active state. The shorter C3 enters more shallowly, so at low concentrations, it tends to occupy space rather than trigger a signal.

In comparison: CBD and CBG have identical molecular formulas and differ only in the geometry of the molecule. THC and THCV differ in their atomic composition. This is a rare situation where shortening the chain produces an opposite biological effect instead of weakening the same action.

How is THCV produced in the cannabis plant?

THCV is produced from a different precursor than THC. The plant builds THC from cannabigerolic acid (CBGA), and THCV from cannabigerovarinic acid (CBGVA). The divergence starts even earlier, as the first pathway uses olivetolic acid, while the second uses divarinolic acid. This is where the shortened side chain comes from.

The enzyme THCA synthase handles both pathways. It converts CBGA into THCA and CBGVA into THCVA. Active forms appear only after decarboxylation, which occurs under the influence of temperature and time. Fresh flower mainly contains acidic forms, which do not bind to the CB1 receptor like THC.

How much THCV can you find in the plant? In typical European strains of Cannabis sativa L., the content does not exceed 0.1%. In African lines, it reaches 0.5-3% (Frontiers in Plant Science, 2021). Only targeted breeding selection raises this result to 5-8%, and such strains are created solely for research and legal cannabis markets.

This arithmetic has very practical consequences. To consume 10 mg of THCV from a flower containing one percent of this cannabinoid, about one gram of material is needed. With a five percent strain, 200 mg is sufficient. That’s why breeders are working on THCV-dominant lines, even though the market for them remains niche.

The timing of the harvest also affects the content. Varin cannabinoids appear in the profile earlier than their longer counterparts, so material harvested before the full maturity of the flower usually has a more favorable THCV to THC ratio. However, producers focused on potency harvest later, as that’s when THC content increases. These two goals are in conflict with each other, and the decision is made by the farmer, not the genetics of the strain.

How do THC and THCV interact with the CB1 receptor?

THC is a full agonist of the CB1 receptor, while THCV changes its role depending on the dose. Below 10 mg, it blocks the receptor without activating it. Above 20 mg, it becomes a partial agonist and produces mild psychoactive effects (Drug and Alcohol Dependence, 2021). Such a biphasic profile is an exception among natural cannabinoids.

Activation of CB1 by THC triggers a G protein cascade that reduces the release of neurotransmitters in the central nervous system. Hence, sedation, altered perception of time, and euphoria. The affinity of THC for this receptor is described by a Ki value of around 40-80 nM, placing it among strong ligands.

At low doses, THCV behaves like a neutral antagonist. It occupies the binding pocket but does not shift the receptor into an active state. The net effect is that the presence of THCV weakens what THC does at the same site. However, at higher concentrations, the molecule begins to shift the receptor itself, albeit more weakly and for a shorter duration.

We have noticed that this biphasic nature is the most common source of misunderstandings in conversations with customers. The question usually is, "Does THCV get you high?", and the correct answer starts with "At what dose?" Without this caveat, both answers, affirmative and negative, are half false.

Practically, this means that a patient seeking the pain-relieving effects of THC without the ravenous appetite and tachycardia has a reason to choose a strain with a higher THCV content. Such material does not eliminate the high but mitigates some side effects. This explains the position of strains like Durban Poison in medical programs.

How do THC and THCV affect appetite?

THC stimulates appetite, while THCV suppresses it, and this is not a difference in degree, but in direction. In a 2016 study involving 62 patients with type 2 diabetes, a dose of 5 mg of THCV twice daily reduced fasting glucose by 12% after 13 weeks (Diabetes Care, 2016). THC under the same conditions produces the opposite effect.

The mechanism on the THC side is well described. Activation of CB1 in the arcuate nucleus of the hypothalamus increases the release of ghrelin and neuropeptide Y, and these two substances trigger hunger. The phenomenon colloquially known as munchies is sometimes treated in oncology as a therapeutic benefit, not a side effect.

THCV blocks the same point. By limiting the CB1 signal in the hypothalamus, it extinguishes the appetite cascade and additionally acts on the CB2 receptor and several TRP receptors. Preclinical studies link this to better insulin sensitivity, although there is still a lack of observations longer than a year.

What happens when both cannabinoids are present in one plant? The net effect depends on the proportions. Durban Poison has about 1.5% THCV with 17-20% THC, so appetite still increases, just more gently than with material containing only THC. Users describe this as a lack of a binge, not a lack of hunger.

The dietary cannabinoid nickname that industry media assigned to THCV in 2020 captures half the truth. Appetite suppression is real and measurable, but the scale of the effect is in the kilograms over several weeks, not a breakthrough in obesity treatment.

What have clinical studies shown about THCV?

There is little clinical data on THCV, but the available data points in one direction. A randomized study from 2016 included 62 patients with type 2 diabetes and compared placebo, THCV alone, CBD alone, and a combination of both. The strongest hypoglycemic effect was achieved with THCV alone at a dose of 5 mg twice daily (Diabetes Care, 2016).

A second study, from 2020, included 41 individuals with obesity and a BMI above 30. A dose of 10 mg of THCV twice daily for 12 weeks resulted in an average weight reduction of 3.2 kg compared to placebo and an improvement in insulin sensitivity of about 15%. All participants completed the protocol.

Tolerance is a value in itself here. In studies of anti-obesity drugs, 20-30% of participants usually drop out due to side effects. In the cited study, no one reported psychoactive effects, and the dropout rate was zero. With a new molecule, such a result means as much as the efficacy itself.

On the THC side, the body of evidence is incomparably larger. A meta-analysis from 2019 included 23 clinical studies and 1847 patients. THC increased energy intake by about 450 kcal per day in patients with cachexia due to AIDS and by 300 kcal in cancer patients, with effects starting after 30-60 minutes.

The research registry recorded seven phase three trials involving THCV in 2024 (ClinicalTrials.gov, 2024). No product containing this cannabinoid has yet been registered, while THC is an ingredient in fourteen registered drugs in Europe and the United States.

Does THCV act psychoactively like THC?

Not in typical doses, and that’s where the whole difference lies. In comparative studies, the subjective intensity of the high from THCV reaches 30-40% of the intensity from an equivalent dose of THC (Cannabis and Cannabinoid Research, 2022). The reason lies in the partial agonism: THCV only shifts the receptor halfway.

THC binds to CB1 throughout the brain, and each area contributes its part to the experience. The limbic system is responsible for euphoria, the prefrontal cortex for altered perception of time, and the hippocampus for weakening short-term memory. Additionally, the cerebellum contributes to poorer motor coordination. Together, this results in a profile lasting 2-4 hours after inhalation.

THCV breaks down into three thresholds. Below 10 mg, most studies do not report measurable psychoactive effects. The range of 15-25 mg provides mild euphoria and mood enhancement without coordination disturbances. Above 50 mg, the profile approaches that of THC, but the duration of action still closes within 60-90 minutes (Drug and Alcohol Dependence, 2021).

Clinical descriptions repeatedly mention a clear high. Users report a lack of drowsiness, lack of binge eating, and lack of confusion. That’s why strains rich in THCV are suitable for daytime medical use, where the patient must maintain the ability to work.

The marketing shorthand "THCV is THC without the high" is only true for doses below 10 mg. Above this threshold, the description ceases to correspond to reality. A producer who uses it without a dose caveat sells incomplete information, and the buyer pays for it with their own surprise.

What side effects do THC and THCV have?

The THC profile is described in detail, while the THCV profile is still estimated. After THC, the most common effects are dry mouth in 88% of users, red eyes in 72%, and tachycardia in 54% (Cannabis and Cannabinoid Research, 2019). Most effects wear off after 4-6 hours.

This list also includes short-term memory disturbances in 41% of respondents, reduced coordination in 38%, and anxiety or paranoia at high doses in 23%. The latter two account for most unpleasant experiences of those who take too high a dose at the start.

THCV appears to be milder, but the research sample is small. Reported effects include mild dry mouth, transient appetite reduction, and rarely anxiety at high doses. No significant tachycardia or typical memory disturbances have been recorded. The lack of long-term studies necessitates treating this picture as preliminary.

Another matter is drug interactions. Both cannabinoids are metabolized by cytochrome P450 enzymes, mainly CYP2C9 and CYP3A4. Many anticoagulants, anticonvulsants, and antidiabetic drugs pass through the same pathways, so combining them requires a conversation with a doctor, not personal calculation.

In its 2018 report, WHO did not include THCV among controlled substances, while THC remains in Schedule I of the Convention on Psychotropic Substances. However, the formal difference in status does not translate into practice, as products containing THCV almost always also contain THC.

There is also an issue that manufacturers are reluctant to discuss. Most reported adverse effects from cannabis products do not stem from the cannabinoid itself, but from dosing errors or material contamination. Residues of pesticides and heavy metals appear in batches outside the controlled supply chain. An analysis certificate covering these parameters speaks more about product safety than the declared cannabinoid content.

Jaki jest status prawny THC i THCV w Polsce w 2026 roku?

THC is a controlled substance in Poland, and the limit for its content in hemp flower is 0.3% (Dz.U. 2005 nr 179 poz. 1485 with later amendments). THCV does not appear on the list of controlled substances. However, practically every product with detectable THCV also contains THC, so it is subject to the same regulations.

The Anti-Narcotics Act lists THC and its synthetic derivatives. Natural cannabinoids from hemp, including CBD, CBG, and THCV, remain outside drug control as long as the THC content in the product does not exceed the threshold. Above that, the product is classified as a drug.

Medical marijuana operates under separate rules. Since 2017, a doctor can issue a prescription for products with THC above the threshold. The program covered about 115,000 patients in 2024, with an annual growth rate of 40% (Hemp Facts, 2024). The number of pharmacies fulfilling such prescriptions is also increasing.

The distinction between species has legal significance. Hemp varieties listed in the European register can be grown freely. Plants with THC content above the threshold require a separate permit. The store u Bucha only sells products from hemp that comply with the Polish limit, which you can check in the category dried hemp.

Outside of Poland, the situation is not uniform. Switzerland allows one percent THC in flower, Germany 0.2%, and from 2024 allows adults to possess a certain amount of high-THC material. THCV itself is not controlled in any of these countries.

How to calculate the 0.3% THC limit in the finished product?

The limit refers to the dry mass of the product, not the declared potency of the cannabinoid. For flower, the conversion is simple: a gram of material can contain up to 3 mg of THC. For oil, you need to consider the mass of the entire contents of the bottle, not the percentage of cannabidiol stated on the label.

An example with numbers. A 10 ml bottle with 1000 mg of cannabidiol is labeled as a ten percent oil. However, the THC percentage is calculated from the mass of the entire contents, not from the mass of CBD. Broad-spectrum formulas have THC removed to zero, while full-spectrum formulas typically contain several milligrams per bottle.

This interpretation has been contentious. A ruling by the Supreme Court in 2022 confirmed that the threshold pertains to the total THC content in the final product. Attempts to break down the result into individual isomers or to sum it with other cannabinoids do not change the legal classification of such goods.

A practical conclusion for the buyer is: the analysis certificate (COA) weighs more than the description on the packaging. The document provides the content of individual cannabinoids in milligrams per gram or as a percentage of mass. Without it, the manufacturer's declaration remains just that—a declaration that no one has verified.

Additionally, there is a layer of food regulation. EFSA treats most cannabinoids from hemp as novel food requiring authorization, and the procedure is still ongoing. Therefore, hemp products are sold in Poland as collectibles or cosmetics. This is a tolerated solution, but not a final one.

The buyer pays for this ambiguity in one specific way. Since the product is not formally food, the manufacturer does not have to provide usage instructions or a daily serving. Therefore, the description on the packaging can be sparse, and information about cannabinoid content is relegated to a document that must be accessed separately. Stores that maintain complete batch documentation stand out more than would be expected from the price.

In which cannabis strains is THCV found?

THCV primarily appears in African and South Asian lines, typically in the range of 0.5-3%. Durban Poison, a classic sativa from South Africa, contains 1.0-1.5% THCV with 17-20% THC. Varieties selected for this purpose reach up to 5-8% (Frontiers in Plant Science, 2021).

The geographical distribution is not coincidental. Lines adapted to hot and dry climates produce more varin cannabinoids, which have a short C3 chain. European fiber hemp, selected for centuries for fiber and seeds, contains THCV only in trace amounts.

Among the strains rich in this cannabinoid, Durban Poison, Pineapple Purps, and Doug’s Varin are most often mentioned. The latter, bred in California in 2008, was the first commercial line with THCV content above four percent. Analyses show it contains 5-7% THCV with 6-8% THC, which reverses the usual ratio.

Pineapple Purps was created by crossing Doug’s Varin with the Pineapple strain. It typically contains 3-5% THCV, 8-12% THC, and a distinct terpene profile with limonene and pinene. In Europe, availability is limited to a few markets, and in Poland, the strain has not been registered in the medical program.

Polish fiber strains, such as Finola, Felina 32, or Białobrzeskie, contain THCV in trace amounts. For the consumer, this means a simple fact: you cannot buy material with declared THCV in legal trade, and what you receive is a natural admixture in full-spectrum flower.

It's also worth reading strain names on labels carefully. The same trade name may be used by different breeders for material with a different profile, as the register of fiber hemp strains describes genetics, not the finished cannabinoid composition of the batch. The outcome of a laboratory test of a specific delivery determines it. If the seller provides only the name and percentage of one cannabinoid, the rest of the profile remains unknown.

How long does THC last, and how long does THCV last?

THCV acts noticeably shorter. After inhalation, effects appear in 5-15 minutes and wear off after 60-90 minutes, while THC lasts 2-4 hours (Cannabis and Cannabinoid Research, 2022). Oral administration prolongs both durations, but the ratio between them remains the same.

The difference is due to pharmacokinetics. THCV is metabolized more quickly by the CYP2C9 and CYP3A4 enzymes, with a half-life of 3-4 hours. THC metabolites remain in the plasma for 20-30 hours. Active THCV derivatives disappear faster and do not accumulate in fat tissue to a comparable extent.

After inhalation, THC reaches peak blood concentration in 5-10 minutes with a bioavailability of 10-35%, depending on the technique and equipment used. Vaporization performs better than smoking in this regard. When taken orally, bioavailability drops to 4-12% because the liver converts THC into 11-hydroxy-THC, a compound that is more psychoactive than the original substance.

THCV reaches its peak after inhalation in 3-8 minutes with a bioavailability of 15-30%. Orally, it falls within the range of 6-18%, with the peak occurring at 1.5-2.5 hours. The entire action cycle closes in about half the time required for THC, which can be a decisive argument when planning the day.

Drug tests do not distinguish between the two compounds. The THC-COOH metabolite can be detected in urine for 3-30 days depending on the frequency of use, while THCV is detectable for a shorter period, typically 2-7 days. However, the antibodies used in screening tests can give cross-reactive results, so a positive result does not clarify the source.

What are the therapeutic applications of THC and THCV?

THC has a history of forty years of clinical use, while THCV is just entering the third phase of research. In 2024, THC was an ingredient in fourteen registered preparations in Europe and the United States, while THCV had seven third-phase trials recorded without a single registration (ClinicalTrials.gov, 2024).

Clinically confirmed indications for THC include chronic pain, spasticity in multiple sclerosis, and nausea and vomiting after chemotherapy. Additionally, it is used for cachexia, Tourette's syndrome, and some drug-resistant epilepsy cases. Sativex, a preparation containing equal amounts of THC and CBD, has been registered in Poland since 2012.

Neuropathic pain shows the best data. A meta-analysis from 2021 included 18 randomized studies and 2283 patients, noting an average pain reduction of 30-40% compared to placebo. The effect was stronger in peripheral pain than in central pain, with effective doses ranging from 2.5 to 10 mg per day.

THCV is being studied for obesity, type 2 diabetes, and metabolic syndrome, as well as in Parkinson's disease and psychosis. The antagonism of CB1 provides a theoretical basis for antipsychotic action, which has so far only been confirmed in animal models.

The psychiatric direction requires caution on both sides. A meta-analysis from 2019 confirmed the link between regular use of high-potency THC material and an increased risk of schizophrenia in individuals with a family history. This is a warning that is not mitigated by the presence of THCV in the same plant.

What is the entourage effect involving THC and THCV?

The entourage effect refers to the mutual modification of the actions of cannabinoids and terpenes, described by Russo and Mechoulam in the British Journal of Pharmacology in 2011 (PMC, British Journal of Pharmacology, 2011). In the case of THC and THCV, the interaction is bidirectional: THC enhances some effects of THCV, while THCV mitigates some side effects of THC.

In animal studies, a mixture of both cannabinoids in a 3:1 ratio provided stronger analgesic effects than THC alone, with less tachycardia and weaker sedation. The mechanism is based on the fact that the partial agonism of THCV wins the competition for receptors in certain brain structures.

Patients reached this conclusion earlier than the literature. Durban Poison gained a reputation as a work strain precisely because it combines moderate THC with high THCV. The analgesic effect remains, but without the characteristic sinking into the couch after a larger dose.

Terpenes add another layer. Myrcene deepens sedation, limonene improves mood, and beta-caryophyllene activates the CB2 receptor and has anti-inflammatory effects. Pinene is associated with better concentration, while alpha-humulene is linked to appetite suppression, which aligns with the direction THCV is taking.

This is where the interest in strains with three strong components at once comes from. Growers in North America are selecting lines that combine THC, THCV, and CBD in one profile, hoping for therapeutic effects with minimal side effects. This is the direction for the next decade, not just for today.

How to dose products with THC and THCV?

Both substances require titration according to the principle of start low, go slow (Project CBD, 2023). For THC, the starting dose is in the range of 2.5-5 mg sublingually or via inhalation. For THCV, the starting point is 5-10 mg. In the medical marijuana program, the scheme is determined by the doctor, not the patient.

The first contact with THC can be stronger than someone without experience might expect. A reaction to 5 mg in a novice can correspond to a reaction to 20 mg in a person with tolerance. Tolerance builds up over 2-4 weeks of regular use, and a break lasting 7-14 days largely reverses it.

THCV behaves more predictably. The dose-effect relationship is approximately linear up to a plateau around 30-40 mg. Higher doses do not increase potency but only prolong the duration. In metabolic studies, 10 mg per day was typically used, divided into two doses.

The route of administration shifts the entire scale. Inhalation requires the least, sublingual administration is intermediate, and oral administration requires two to three times more, as bioavailability decreases after passing through the liver. With edible products, there is a delay of up to two hours, which can lead to overdose due to impatience.

In the Polish medical program, a typical start is 0.1 g of dried herb daily, divided into two or three doses, with an increase of 0.1 g weekly until the desired effect is achieved. Ready-made preparations are dosed more precisely: one spray of Sativex contains 2.7 mg of THC and 2.5 mg of CBD, and the typical daily dose ranges from 4 to 12 sprays.

What myths have arisen around THC and THCV?

There are many misunderstandings, and there are more regarding THCV than THC. According to a consumer survey from 2023, about 51% of respondents had misconceptions about THC, while the percentage for THCV reached 72% (EMCDDA, 2023). The reason is simple: less data, more marketing.

The first myth claims that THCV promotes weight loss without diet and exercise. Clinical studies show a weight reduction of about 1.9-3.2 kg over 12-16 weeks. This result is comparable to a moderate change in habits, not to incretin medications, which can lead to a 10-15% weight loss over a year.

The second myth suggests that THC is completely illegal in Poland. This is not true: products below the threshold of 0.3% are legal, and medical marijuana with higher content is available by prescription. Cultivation, possession, and sale outside this system remain illegal.

The third myth concerns the replacement of medications. THCV reduced fasting glucose by 12% over 13 weeks, while metformin reduces it by 20-30%. Discontinuing diabetes treatment in favor of a cannabinoid is dangerous, especially since both pass through the same liver enzymes.

The fourth myth assures that strains with THCV are not psychoactive. Durban Poison has 17-20% THC alongside 1-1.5% THCV, while Doug's Varin has 6-8% THC alongside 5-7% THCV. In both cases, THC sets the tone for the experience. Pure THCV isolates, which are practically non-psychoactive at low doses, remain a rarity in research.

The fifth myth concerns testing. There is a belief that material with a predominance of THCV will not yield a positive result in roadside or workplace tests. Screening tests detect the THC-COOH metabolite, and the antibodies used in them cross-react with derivatives of similar structure. Legal dried herb with THC content below the threshold can also yield a positive result with frequent use.

Co realnie kupisz w polskim sklepie?

You won't find a product with declared THCV for sale. Searching the u Bucha catalog returns no items with this cannabinoid in the description, and THCV-dominant strains are not registered in the Polish medical program. What you actually get is full-spectrum flower, in which THCV is present only in trace amounts.

The hemp flower category currently includes 34 items. Below are eight of them, selected to showcase the range of formats and conversions. Prices are sourced from the Store API of the shop, as of August 8, 2026, and may change between publication and your purchase.

The conclusion from this comparison is simple: the price per gram is determined by the packaging format, not the strain. The same Northwest costs 35.00 zł per gram in a one-gram package and 14.00 zł in a ten-gram package. The two-and-a-half-fold difference has nothing to do with the cannabinoid profile of the material.

Ile kosztuje gram suszu konopnego?

The range is broader than the shelf prices suggest. In the eight items from the previous table, the cost of one gram varies from 7.50 zł to 35.00 zł, which is almost a fivefold difference. The size of the package explains almost all of this range.

The cheapest conversion comes from trim, which is material from smaller fragments of the flower. At 75 zł for ten grams, it comes out to 7.50 zł per gram. The most expensive is the one-gram package: 35 zł per gram, which is almost five times more for material with the same cannabinoid profile.

Mid-range packages are five grams, costing between 15.00 zł and 20.00 zł per gram. This is a range where differences arise from the strain and the selection method of the material, not just the size of the package. Above twenty złoty per gram, you mainly pay for a small portion.

Our observations indicate that one- and two-gram packages serve as samples. Customers buy them to test the strain, and upon reordering, they switch to five or ten grams. In such a scenario, overpaying at the start is a conscious cost of testing, not a purchasing mistake.

If you consider the cost of use rather than the cost of a one-time purchase, the conversion per gram is the right measure. With 0.1 g daily, a ten-gram package for 140 zł lasts for one hundred days, which amounts to 1.40 zł per day. The same calculation for a one-gram package gives 3.50 zł per day.

When to choose THC and when to choose THCV?

The choice depends on the purpose and what is legally available. For chronic pain, spasticity in multiple sclerosis, and nausea after chemotherapy, THC is indicated, available in Poland by prescription Rpw. For appetite control and the need to maintain concentration during the day, THCV performs better.

The pain scenario has an established standard. A combination of THC and CBD in a one-to-one ratio, as in Sativex, provides a 30-40% reduction in pain in randomized studies with doses of 5-15 mg of THC daily. THCV is not a component of therapy here, although it does not interfere in a strain containing both cannabinoids.

The metabolic scenario looks the opposite. THC increases appetite, so it works against the goal of weight control. THCV at a dose of 10 mg daily, divided into two portions, shows effects after 4-8 weeks, but only in combination with dietary changes and increased activity levels.

The daily scenario, meaning work and concentration, is the domain of strains with high THCV. The problem is that such strains are not legally available in Poland. A real alternative remains full-spectrum flower with low THC content, which does not impair work ability.

For most Polish consumers, the practical answer is thus: full-spectrum flower with legal THC content and a complete profile of minor cannabinoids. For indications requiring higher doses, the path leads through a doctor's office and a prescription Rpw, not through an online store.

Frequently Asked Questions

What is the chemical difference between THC and THCV?

THC has a pentyl side chain (C5), while THCV has a propyl chain (C3). This difference of two carbon atoms changes the affinity for the CB1 receptor. THC is a full agonist, while THCV is an antagonist at low doses and a partial agonist at high doses (Pharmacological Reviews, 2020). The molecular formulas of both molecules are also different.

Does THCV act psychoactively like THC?

Not in typical doses. Below 10 mg, THCV blocks the CB1 receptor and does not produce a high. Above 20 mg, it becomes a partial agonist and may produce mild, shorter psychoactive effects (Drug and Alcohol Dependence, 2021). The effects of THCV last 60-90 minutes compared to 2-4 hours for THC.

Are THC and THCV legal in Poland in 2026?

THC is a controlled substance, and the limit of its content in the dry product is 0.3% (Dz.U. 2005 nr 179 poz. 1485 with later amendments). THCV is not on the list of controlled substances, but almost every product containing THCV also contains THC. Medical marijuana requires a prescription Rpw.

How do THC and THCV affect appetite?

THC stimulates appetite by activating CB1 receptors in the hypothalamus, which increases the release of ghrelin and neuropeptide Y. THCV works in the opposite way and blocks the same pathway. In a 2016 study, a dose of 5 mg twice daily reduced fasting glucose by 12% and decreased body weight (Diabetes Care, 2016).

In which cannabis strains is THCV found?

Mainly in African and Asian strains. Durban Poison, Doug’s Varin, and Pineapple Purps contain 0.5-3% THCV. European hemp typically has less than 0.1% (Frontiers in Plant Science, 2021). Strains selected for this purpose reach 5-8%, but are not available in the Polish market.

Does THCV help with weight loss?

Studies show a reduction in body weight of 1.9-3.2 kg over 12-16 weeks with a dose of 5-10 mg twice daily (Diabetes Care, 2016). This effect is comparable to a moderate change in dietary habits. THCV is not a registered drug for obesity and does not replace diet or physical activity.

How long does THCV last compared to THC?

Shorter. After inhalation, the effects of THCV begin in 3-8 minutes and wear off after 60-90 minutes, while THC lasts 2-4 hours (Cannabis and Cannabinoid Research, 2022). The difference arises from the faster metabolism of THCV by the CYP2C9 and CYP3A4 enzymes and a shorter half-life.

Czy w sklepie u Bucha kupisz produkt z THCV?

There are no products with declared THCV. Searching the catalog returns no results for this cannabinoid. The category dried hemp contains 34 full-spectrum products, in which THCV is present in trace amounts, priced from 7.50 PLN to 35.00 PLN per gram.

Summary: THC or THCV, what to choose?

THC and THCV are sister molecules with opposing profiles. THC is a full agonist of the CB1 receptor. It acts strongly and for a long time, produces a psychoactive effect, and at the same time stimulates appetite. THCV, with a shorter C3 chain, at low doses blocks the same receptor, does not produce a high, suppresses appetite, and wears off after 60-90 minutes.

For the Polish consumer, a realistic option remains full-spectrum dry product with trace amounts of minor cannabinoids, within the limit of 0.3% THC. For more serious therapeutic indications, the path leads through a prescription Rpw, not through self-directed supplementation.

THCV remains a cannabinoid of the future, but a future with a timeline. Phase three studies for obesity, diabetes, and schizophrenia are ongoing, and the first registrations are expected between 2027-2030. Until then, the only access remains a natural admixture in hemp dry product.

A good decision starts with understanding the difference between these molecules and ends with checking the certificate of analysis of a specific product. The rest, including dosage and frequency, requires a conversation with a doctor wherever chronic illness or long-term medications are involved.

If you want to check what is actually available, take a look at the category dried hemp or to hemp oils.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult a doctor, especially if you are taking other medications, are pregnant, or breastfeeding.

Author: Michał Waluk · Opublikowano: 2026-04-27 · Aktualizacja: 2026-08-08